Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Telemedicine may play in the diagnosis of eye diseases

Telemedicine may play in the diagnosis of eye diseases

Fenofibrate intervention and event lowering in diabetes

Fenofibrate intervention and event lowering in diabetes

Simple technique helps retinal patients detect vision loss quickly and cheaply

Simple technique helps retinal patients detect vision loss quickly and cheaply

Effectiveness of interventions to promote screening for diabetic retinopathy

Effectiveness of interventions to promote screening for diabetic retinopathy

Insulin pens may offer diabetics substantial savings

Insulin pens may offer diabetics substantial savings

Age-related macular degeneration patient receives investigational eye drops

Age-related macular degeneration patient receives investigational eye drops

Staffordshire screening programme on track to screen over 35,000 diabetes patients

Staffordshire screening programme on track to screen over 35,000 diabetes patients

Omega-3 polyunsaturated fatty acids protect against retinopathy

Omega-3 polyunsaturated fatty acids protect against retinopathy

Basically eating fish may protect against type of blindness

Basically eating fish may protect against type of blindness

FDA approves Norditropin for short stature in children with Noonan syndrome

FDA approves Norditropin for short stature in children with Noonan syndrome

Researchers use gene therapy to restore sight in mice

Researchers use gene therapy to restore sight in mice

Insulin therapy shown to treat early experimental diabetic retinopathy

Insulin therapy shown to treat early experimental diabetic retinopathy

People with diabetes need more than sunglasses to protect their eyes

People with diabetes need more than sunglasses to protect their eyes

New type of laser for providing high-resolution 3-D images of the retina

New type of laser for providing high-resolution 3-D images of the retina

New hope for diabetic retinopathy sufferers

New hope for diabetic retinopathy sufferers

Community based digital eye screening programme set to expand

Community based digital eye screening programme set to expand

Lexicon Reports on anti-angiogenesis target discoveries

Lexicon Reports on anti-angiogenesis target discoveries

Blindness added to the risk list of obesity

Blindness added to the risk list of obesity

New class of experimental drug that targets master regulator gene called c-Jun

New class of experimental drug that targets master regulator gene called c-Jun

New drug helps diabetics keep their sight

New drug helps diabetics keep their sight

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.